1-3 of 3
John Sapp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study

Leah E. Cahill, Rachel A. Warren, Allie S. Carew, Andrew P. Levy, John Sapp, Michelle Samuel, Elizabeth Selvin, Samantha K. Lavallée, Neil Poulter, Michel Marre, Stephen Harrap, Giuseppe Mancia, Katie Harris, John Chalmers, Mark Woodward, Eric B. Rimm
Journal: Diabetes Care
Diabetes Care 2024;47(5):835–843
https://doi.org/10.2337/dc23-2165
Published: 14 March 2024
View article titled, Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
Open the PDF for Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study in another window
Journal Articles

The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants

Leah E. Cahill, Rachel A. Warren, Allie S. Carew, Andrew P. Levy, Henry N. Ginsberg, John Sapp, Orit Lache, Eric B. Rimm
Journal: Diabetes Care
Diabetes Care 2023;46(11):1941–1948
https://doi.org/10.2337/dc23-0760
Published: 28 August 2023
View article titled, The Relationship Between Time-Varying Achieved HbA<sub>1c</sub> and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants
Open the PDF for The Relationship Between Time-Varying Achieved HbA<sub>1c</sub> and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants in another window
Journal Articles

Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial

Rachel A. Warren, Allie S. Carew, Pantelis Andreou, Christine Herman, Andrew P. Levy, Henry N. Ginsberg, John Sapp, Eric B. Rimm, Susan Kirkland, Leah E. Cahill
Journal: Diabetes Care
Diabetes Care 2022;45(1):241–250
https://doi.org/10.2337/dc21-1429
Published: 16 November 2021
View article titled, Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial
Open the PDF for Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial in another window